左炔诺孕酮宫内缓释系统对子宫腺肌病患者性功能的影响  

Effect of Levonorgestrel Intrauterine System on Sexual Function of Patients with Adenomyosis

作　　者：吴文英[1] 赵祥峰[2] 洪莉[1] 陈璐[1] 胡敏[1] 孙青[1] 朱雪娇[1] 

机构地区：[1]武汉大学人民医院妇产科,湖北武汉430060 [2]解放军第161医院,湖北武汉430010

出　　处：《武汉大学学报（医学版）》2011年第4期523-525,共3页Medical Journal of Wuhan University

基　　金：湖北省人口与计划生育委员会基金资助项目(编号:JS-2010016)

摘　　要：目的:探讨左炔诺孕酮宫内缓释系统治疗子宫腺肌病后对患者性功能的影响。方法:选择因子宫腺肌病放置左炔诺孕酮宫内缓释系统的患者40例,采用国际女性性功能评估量表评价患者治疗前1月、治疗后6月、治疗后12个月性功能情况。结果:35例患者顺利完成随访,随访率87.5%。与治疗前比较,治疗后12个月患者性功能各项指标均明显改善,而治疗后6个月并无显著改善。结论:左炔诺孕酮宫内缓释系统治疗对子宫腺肌病患者的性功能的改善有较好的临床疗效。Objective：To explore the changes of sexual function of patients with adenomyosis after the treatment of Levonorgestrel releasing intrauterine system.Methods：The female sexual function of forty patients with adenomyosis after LNG-IUS impantation was assessed by Brief Index of Sexual Function for Women（BISF-W） one month before treatment,6 and 12 months after treatment.Results：Thirty-five patients were successfully followed up,and the follow-up rate was 87.5%.Not until 12 months after treatment,the sexual function improved significantly.Conclusion：Levonorgestrel releasing intrauterine system（LNG-IUS） treatment has significant effect on sexual functional recovery in patients with adenomyosis.

关 键 词：左炔诺孕酮宫内缓释系统 子宫腺肌病 

分 类 号：R453[医药卫生—治疗学]